Use of radiochemotherapy for inoperable non-small cell lung cancer
Nemkova, E.V.; Mus, V.F.
Voprosy Onkologii 54(1): 78-81
2008
ISSN/ISBN: 0507-3758 PMID: 18416063 Document Number: 619022
The study was concerned with efficacy and tolerability of radiochemotherapy for inoperable non-small cell lung cancer using fractionated single focal dose of radiation in conjunction with vinorelbine or 5-fluorouracil. The treatment proved moderately toxic and was frequently followed by complete regression and survival lasting 12-36 months. Also, it was cost-effective due to shorter courses of radiotherapy.
Document emailed within 1 workday
Related Documents
Masuda, N. 1997: Combination chemotherapy in the treatment of inoperable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 379-383Fietkau, R. 2001: Controversial treatment of brain metastases of small-cell lung cancer. Randomized comparison of chemotherapy alone and radiochemotherapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 177(6): 314-316
Nishimura, M.; Sugiura, T.; Urata, A.; Ota, K. 1985: Current status in the treatment of inoperable non-small cell lung cancer (NSCLC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 54-60
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Decker, R.H.; Tanoue, L.T.; Colasanto, J.M.; Detterbeck, F.C.; Wilson, L.D. 2006: Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities Oncology 20(8): 899-905; Discussion: 905-908, 913
Manegold, C. 1998: Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer Seminars in Oncology 25(4 Suppl 9: 18-22
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
Johnson, D.H. 1990: Overview of ifosfamide in small cell and non-small cell lung cancer Seminars in Oncology 17(2 Suppl 4: 24-30
Dhabhar, B.N.; Malhotra, H.; Advani, S.H. 1992: Incidence of lung cancer and advances in non-small cell lung cancer Journal of the Association of Physicians of India 40(7): 493
Stamatelopoulos, A.; Kadjianis, F.; Zoganas, L. 2009: Non-small cell lung cancer: pulmonary parenchyma resection in lung-compromised patients Journal of BUON: Official Journal of the Balkan Union of Oncology 14(2): 183-188
Momozane, T.; Higashiyama, M.; Maeda, J.; Okami, J.; Oda, K.; Imamura, F.; Yoneda, K.; Takenaka, A.; Kodama, K. 2009: Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 117-121